Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.405 USD | +2.01% | -15.30% | -32.15% |
05-08 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.15% | 515M | |
+29.29% | 48.16B | |
-0.71% | 41.73B | |
+43.85% | 41.03B | |
-5.31% | 28.77B | |
+10.60% | 25.59B | |
-21.70% | 18.96B | |
+8.11% | 12.92B | |
+26.74% | 12.03B | |
-3.13% | 11.77B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- Olema Pharmaceuticals : Canaccord Genuity Initiates Coverage on Olema Pharmaceuticals With Buy Rating, $60 Price Target